Renal endothelial dysfunction in acute kidney ischemia reperfusion injury

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 14, Issue 1, 2014, Pages 3-14

  Basile, David P ^a   Yoder, Mervin C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Chronic kidney disease; Inflammation; Rarefaction; Repair

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY DISEASE; DELAYED GRAFT FUNCTION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; NONHUMAN; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STEM CELL; VASOCONSTRICTION; ANIMAL; COMPLICATION; IMMUNOLOGY; KIDNEY; PATHOPHYSIOLOGY; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; HEMODYNAMICS; HUMANS; KIDNEY; REPERFUSION INJURY;

EID: 84905656013     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X1401140724093505     Document Type: Article

References (167)

1. Liangos, O.; Wald, R.; O'Bell, J.W.; Price, L.; Pereira, B.J.; Jaber, B.L. Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients: A National Survey. Clin. J. Am. Soc. Nephrol., 2006, 1(1), 43-51.
2. Bagshaw, S.M.; Laupland, K.B.; Doig, C.J.; Mortis, G.; Fick, G.H.; Mucenski, M.; Godinez-Luna, T.; Svenson, L.W.; Rosenal, T. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit. Care., 2005, 9(6), R700-9.
3. Levy, E.M.; Viscoli, C.M.; Horwitz, R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA, 1996, 275(19), 1489-94.
4. Mehta, R.L.; Chertow, G.M. Acute renal failure definitions and classification: time for change? J. Am. Soc. Nephrol., 2003, 14(8), 2178-87.
5. Nash, K.; Hafeez, A.; Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis., 2002, 39(5), 930-6.
6. Uchino, S.; Kellum, J.A.; Bellomo, R.; Doig, G.S.; Morimatsu, H.; Morgera, S.; Schetz, M.; Tan, I.; Bouman, C.; Macedo, E.; Gibney, N.; Tolwani, A.; Ronco, C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA, 2005, 294(7), 813-8.
7. Wald, R.; Quinn, R.R.; Luo, J.; Li, P.; Scales, D.C.; Mamdani, M.M.; Ray, J.G. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA, 2009, 302(11), 1179-85.
8. Chertow, G.M.; Burdick, E.; Honour, M.; Bonventre, J.V.; Bates, D.W. Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients. J. Am. Soc. Nephrol., 2005, 16(11), 3365-3370.
9. Chertow, G.M.; Christiansen, C.L.; Cleary, P.D.; Munro, C.; Lazarus, J.M. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch. Intern. Med., 1995, 155(14), 1505-11.
10. Ishani, A.; Xue, J.L.; Himmelfarb, J.; Eggers, P.W.; Kimmel, P.L.; Molitoris, B.A.; Collins, A.J. Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrol., 2009, 20(1), 223-8.
11. Liano, F.; Junco, E.; Pascual, J.; Madero, R.; Verde, E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. Suppl., 1998, 66, S16-24.
12. Liano, F.; Pascual, J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int., 1996, 50(3), 811-8.
13. Lo, L.J.; Go, A.S.; Chertow, G.M.; McCulloch, C.E.; Fan, D.; Ordonez, J.D.; Hsu, C.Y. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int., 2009, 76(8), 893-9.
14. Morgera, S.; Kraft, A.K.; Siebert, G.; Luft, F.C.; Neumayer, H.H. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis., 2002, 40 (2), 275-9.
15. Schiffl, H. Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients. Nephrol. Dial. Transplant., 2006, 21(5), 1248-52.
16. Amdur, R.L.; Chawla, L.S.; Amodeo, S.; Kimmel, P.L.; Palant, C.E. Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int., 2009, 76(10), 1089-97.
17. Waikar, S.S.; Winkelmayer, W.C. Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA, 2009, 302(11), 1227-9.
18. Xue, J.L.; Daniels, F.; Star, R.A.; Kimmel, P.L.; Eggers, P.W.; Molitoris, B.A.; Himmelfarb, J.; Collins, A.J. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J. Am Soc. Nephrol., 2006, 17, 1135-1142.
19. Sutton, T.A.; Fisher, C.J.; Molitoris, B.A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Intern., 2002, 62(5), 1539-49.
20. Bonventre, J.V.; Weinberg, J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am Soc. Nephrol., 2003, 14, 2199-2210
21. Hollenberg, N.K.; Epstein, F.H.; Rosen, S.; Basch, R.; Oken, D.; Merrill, Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicne(Balt), 1968, 47(6), 455-74.
22. Karlberg, L.; Norlen, B.J.; Ojteg, G.; Wolgast, M. Impaired medullary circulation in postischemic acute renal failure. Acta Physiologica Scandinavica, 1983, 118(1), 11-7.
23. Hellberg, P.O.A.; Kallskog, O.T.; Ojteg, G.; Wolgast, M. Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. Am. J. Physiol., 1990, 258 (Renal Fluid Electrolyte Physiology), F1018-F1025.
24. Mason, J.; Torhorst, J.; Welsch, J. Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int., 1984, 26, 283-293.
25. Dagher, P.C.; Herget-Rosenthal, S.; Ruehm, S.G.; Jo, S.-K.; Star, R.A.; Agarwal, R.; Molitoris, B.A. Newly developed techniques to study and diagnose acute renal failure. J. Am. Soc. Nephrol., 2003, 14 (8), 2188-98.
26. Sheridan, A.M.; Bonventre, J.V. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr. Opinion Nephrol. Hyperten., 2000, 9(4), 427-34.
27. Park, K.; Chen, A.; Bonventre, J.V. Prevention of kidney ischemia/reperfusion induced functional injury and JNK, p38 and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem., 2001, 276(15), 11870-6.
28. Bonventre, J.V.; Weinberg, J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J. Am. Soc. Nephrol., 2003, 14(8), 2199-210.
29. Bojakowski, K.; Abramczyk, P.; Bojakowska, M.; Zwolinska, A.; Przybylski, J.; Gaciong, Z. Fucoidan improves the renal blood flow in the early stage of renal ischemia/reperfusion in the rat. J Physiol. Pharmacol., 2001, 52(1), 137-143.
30. Cristol, J.P.; Thiemermann, C.; Mitchell, J.A.; Walder, C.; Vane, J.R. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Brit. J. Pharmacol., 1993, 109(1), 188-194.
31. Versteilen, A.M.G.; Korstjens, I.J.M.; Musters, R.J.P.; Groeneveld, A.B.J.; Sipkema, P. Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney. Am. J. Physiol. Renal Physiol., 2006, 291(3), F606-F611.
32. Regner, K.R.; Zuk, A.; Van Why, S.K.; Shames, B.D.; Ryan, R.P.; Falck, J.R.; Manthati, V.L.; McMullen, M.E.; Ledbetter, S.R.; Roman, R.J. Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. Kidney Int., 2008, 75(5), 511-517.
33. Shi, H.; Patschan, D.; Epstein, T.; Goligorsky, M.S.; Winaver, J. Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am. J. Physiol. Renal Physiol. 2007, 293(5), F1512-F1517.
34. Regner, K.; Roman, R. Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. Curr. Opin. Nephrol. Hyperten., 2012, 21(1), 33-38.
35. Saito, M.; Miyagawa, I. Real-time monitoring of nitric oxide in ischemia-reperfusion rat kidney. Urological Res., 2000, 28(2), 141-146.
36. Basile, D.P.; Anderson, M.; Sutton, T.A. Pathophysiology of acute kidney injury. Comprehen. Physiol., 2012, 2, 1303-1353.
37. Molitoris, B.A.; Sutton, T.A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Internat., 2004, 66(2), 496-9.
38. Jo, S.K.; Rosner, M.H.; Okusa, M.D. Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon. Clin. J. Am. Soc. Nephrol., 2007, 2(2), 356-365.
39. Honore, P.; Jacobs, R.; Joannes-Boyau, O.; Verfaillie, L.; De Regt, J.; Van Gorp, V.; De Waele, E.; Boer, W.; Collin, V.; Spapen, H. Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside? Ann. Intensive Care, 2012, 2(1), 24.
40. Blantz, R.C.; Pelayo, J.C. A functional role for the tubuloglomerular feedback mechanism. Kidney Int., 1984, 25(5), 739-746.
41. Fujii, T.; Kurata, H.; Takaoka, M.; Muraoka, T.; Fujisawa, Y.; Shokoji, T.; Nishiyama, A.; Abe, Y.; Matsumura, Y. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur. J. Pharm., 2003, 481(2-3), 241-248.
42. Salman, I.M.; Ameer, O.Z.; Sattar, M.A.; Abdullah, N.A.; Yam, M.F.; Najim, H.S.; Khan, A.H.; Johns, E.J. Role of the renal sympathetic nervous system in mediating renal ischaemic injuryinduced reductions in renal haemodynamic and excretory functions. Pathology, 42(3), 259-266.
43. Wang, W.; Falk, S.A.; Jittikanont, S.; Gengaro, P.E.; Edelstein, C. L.; Schrier, R.W. Protective effect of renal denervation on normotensive endotoxemia-induced acute renal failure in mice. Am. J. Physiol. Renal Physiol., 2002, 283(3), F583-F587.
44. Sreedharan, R.; Devarajan, P.; Van Why, S. Pathogenesis of acute renal failure. In Pediatric Nephrology, 6th ed.; Avner, E.; Harmon, W.; Niaudet, P.; Yoshikawa, N., Eds. Springer-Verlag: Heidleberg, 2009; pp 1579-1602.
45. Nishiyama, A.; Miyatake, A.; Aki, Y.; Fukui, T.; Rahman, M.; Kimura, S.; Abe, Y. Adenosine A1 Receptor Antagonist KW-3902 Prevents Hypoxia-Induced Renal Vasoconstriction. J. Pharmacol. Exp. Therap., 1999, 291(3), 988-993.
46. Wilhelm, S.M.; Simonson, M.S.; Robinson, A.V.; Stowe, N.T.; Schulak, J.A. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Intern., 1999, 55(3), 1011-8.
47. Huang, C.; Huang, C.; Hestin, D.; Dent, P.C.; Barclay, P.; Collis, M.; Johns, E.J. The effect of endothelin antagonists on renal ischaemiaâ€reperfusion injury and the development of acute renal failure in the rat. Nephrol. Dial Transplant., 2002, 17(9), 1578-1585.
48. Knoll, T.; Schult, S.; Birck, R.; Braun, C.; Michel, M.S.; Bross, S.; Juenemann, K.P.; Kirchengast, M.; Rohmeiss, P. Therapeutic administration of an endothelin-A receptor antagonist after acute ischemic renal failure dose-dependently improves recovery of renal function. J. Cardiovasc. Pharmacol., 2001, 37, 483-8.
49. Büyükgebiz, O.; Aktan, A.Ö.; Haklar, G.; Yalçin, A.S.; Yeǧen, C.; Yalin, R.; Ercan, Z.S. BQ-123, a specific endothelin (ET1) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation. Transplant Intern., 1996, 9(3), 201-207.
50. Lopez-Novoa, J.M. Potential role of platelet activating factor in acute renal failure. Kidney Int., 1999, 55(5), 1672-1682.
51. Wang, W.; Zolty, E.; Falk, S.; Summer, S.; Stearman, R.; Geraci, M.; Schrier, R. Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice. Am. J. Physiol. Renal Physiol., 2007, 293(4), F1131-F1136.
52. Tobimatsu, M.; Euda, Y.; Saito, S.; Tsumagari, T.; Konomi, K. Effects of a stable prostocyclin analog on experimental ischemic acute renal failure. Ann. Surg., 1988, 208, 65-70.
53. Vargas, A.; Krishnamurthi, V.; Masih, R.; Robinson, A.; Shchulak, J. Prostaglandin E1 attenuation of ischemic renal reperfusion in the rat. J. Am. Coll. Surg., 1995, 180, 713-717.
54. Gellai, M.; Jugus, M.; Fletcher, T.; DeWolf, R.; Nambi, P. Reversal of postischemic acute renal failure with a selective endothlin-A receptor antagonist. J. Clin. Investig., 1994, 93, 900-906.
55. Boffa, J.J.; Just, A.; Coffman, T.M.; Arendshorst, W.J. Thromboxane Receptor Mediates Renal Vasoconstriction and Contributes to Acute Renal Failure in Endotoxemic Mice. J. Am. Soc. Nephrol., 2004, 15 (9), 2358-2365.
56. Kwon, O.; Phillips, C.L.; Molitoris, B.A. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am. J. Physiol. Renal Fluid & Electrolyte Physiol., 2002, 282, F1012-9.
57. Sutton, T.A.; Mang, H.E.; Campos, S.B.; Sandoval, R.M.; Yoder, M.C.; Molitoris, B.A. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am. J. Physiol. Renal Physiol., 2003, 285(2), F191-8.
58. Hellberg, P.O.; Kallskog, O.; Wolgast, M. Nephron function in the early phase of ischemic renal failure. Significance of erythrocyte trapping. Kidney Intern., 1990, 38, 432-9.
59. Hellberg, P.O.A.; Kallskog, O.; Wolgast, M. Red cell trapping and postischemic renal blood flow. Differences between the cortex, outer and inner medulla. Kidney Int., 1991, 40, 625-631.
60. Brodsky, S.V.; Yamamoto, T.; Tada, T.; Kim, B.; Chen, J.; Kajiya, F.; Goligorsky, M.S. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am. J. Physiol. Renal Fluid & Electrolyte Physiol., 2002, 282(6), F1140-9.
61. Yamamoto, T.; Tada, T.; Brodsky, S.V.; Tanaka, H.; Noiri, E.; Kajiya, F.; Goligorsky, M.S. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am. J. Physiol. Renal Fluid & Electrolyte Physiol., 2002, 282(6), F1150-5.
62. Mattson, D.L.; Lu, S.; Cowley, A.W., Jr. Role of nitric oxide in the control of the renal medullary circulation. Clin. Exp. Pharmacol. Physiol., 1997, 24(8), 587-90.
63. Zou, A.P.; Wu, F.; Cowley, A.W., Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension, 1998, 31, 271-6.
64. Conger, J.D.; Robinette, J.B.; Schrier, R.W. Smooth muscle calcium and endothelium derived relaxing factor in the abnormal vascular responses of acute renal failure. J. Clin. Investig., 1988, 82, 532-537.
65. Wang, W.; Mitra, A.; Poole, B.; Falk, S.; Lucia, M.S.; Tayal, S.; Schrier, R. Endothelial nitric oxide synthase-deficient mice exhibit increased susceptibility to endotoxin-induced acute renal failure. Am. J. Physiol. Renal Physiol., 2004, 287(5), F1044-F1048.
66. Conger, J.D.; Schultz, M.F.; Miller, F.; Robinette, J.B. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Intern., 1994, 46(2), 318-23.
67. Conger, J.D.; Robinette, J.B.; Villar, A.; Raij, L.; Shultz, P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in post-ischemic acute renal failure in rats. J. Clin. Investig., 1995, 96, 631-638.
68. Adams, P.L.; Adams, F.F.; Bell, P.D.; Navar, L.G. Impaired renal blood flow autoregulation in ischemic acute renal failure. Kidney Int., 1980, 18(1), 68-76.
69. Solez, K.; Morel-Maroger, L.; Sraer, J.-D. The Morphology of Acute Tubular Necrosis in Man: Analysis of 57 Renal Biopsies and a Comparison with the Glycerol Model. Medicine, 1979, 58(5), 362-376.
70. Zou, A.P.; Li, N.; Cowley, A.W., Jr., Production and actions of superoxide in the renal medulla. Hypertension, 2001, 37, 547-53.
71. Chen, Y.-F.; Li, P.-L.; Zou, A.-P. Oxidative stress enhances the production and actions of adenosine in the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 281(6), R1808-R1816.
72. Schneider, R.; Raff, U.; Vornberger, N.; Schmidt, M.; Freund, R.; Reber, M.; Schramm, L.; Gambaryan, S.; Wanner, C.; Schmidt, H.H.H.W.; Galle, J. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int., 2003, 64(1), 216-225.
73. Garcia-Criado, F. J.; Eleno, N.; Santos-Benito, F.; Valdunciel, J.J.; Reverte, M.; Lozano-Sanchez, F. S.; Ludena, M.D.; Gomez-Alonso, A.; Lopez-Novoa, J.M. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation, 1998, 66(8), 982-90.
74. Dagher, F.; Pollina, R.M.; Rogers, D.M.; Gennaro, M.; Ascer, E. The value and limitations of L-arginine infusion on glomerular and tubular function in the ischemic/reperfused kidney. J. Vasc. Surgery., 1995, 21(3), 453-8.
75. Schramm, L.; La, M.; Heidbreder, E.; Hecker, M.; Beckman, J.S.; Lopau, K.; Zimmermann, J.; Rendl, J.; Reiners, C.; Winderl, S.; Wanner, C.; Schmidt, H.H. L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. Kidney Int., 2002, 61(4), 1423-32.
76. Schneider, R.; Raff, U.; Vornberger, N.; Schmidt, M.; Freund, R.; Reber, M.; Schramm, L.; Gambaryan, S.; Wanner, C.; Schmidt, H.H.; Galle, J. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int., 2003, 64, 216-25.
77. Kakoki, M.; Hirata, Y.; Hayakawa, H.; Suzuki, E.; Nagata, D.; Tojo, A.; Nishimatsu, H.; Nakanishi, N.; Hattori, Y.; Kikuchi, K.; Nagano, T.; Omata, M. Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J. Am Soc. Nephrol., 2000, 11, 301-309.
78. Sucher, R.; Gehwolf, P.; Oberhuber, R.; Hermann, M.; Margreiter, C.; Werner, E.R.; Obrist, P.; Schneeberger, S.; Ollinger, R.; Margreiter, R.; Brandacher, G. Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury. Kidney Int., 2010, 77(8), 681-689.
79. Sohotnik, R.; Nativ, O.; Abbasi, A.; Awad, H.; Frajewicki, V.; Bishara, B.; Sukhotnik, I.; Armaly, Z.; Aronson, D.; Heyman, S.N.; Nativ, O.; Abassi, Z.A. Phosphodiesterase5 Inhibition Attenuates Early Renal Ischemia/Reperfusion-Induced Acute Kidney Injury: Assessment by measurement of urinary NGAL and KIM-1. Am. J. Physiol. Renal Physiol., 2013, 304(8), F1099-104.
80. Choi, D.E.; Jeong, J.Y.; Lim, B.J.; Chung, S.; Chang, Y.K.; Lee, S.J.; Na, K.R.; Kim, S.Y.; Shin, Y.T.; Lee, K.W. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats. Am. J. Physiol. Renal Physiol., 2009, 297(2), F362-F370.
81. Patel, N.N.; Lin, H.; Toth, T.; Jones, C.; Ray, P.; Welsh, G.I.; Satchell, S.C.; Sleeman, P.; Angelini, G.D.; Murphy, G.J. Phosphodiesterase-5 Inhibition Prevents Postcardiopulmonary Bypass Acute Kidney Injury in Swine. Ann Thorac Surg., 2012, 92(6), 2168-2176.
82. Arriero, M.; Brodsky, S.V.; Gealekman, O.; Lucas, P.A.; Goligorsky, M.S. Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia. Am. J. Physiol. Renal Physiol., 2004, 287(4), F621-7.
83. Denton Mark, D.; Chertow, G.M.; Brady, H.R. Renaldose [ rdquo] dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int., 1996, 50 (1), 4-14.
84. Kellum, J.A.; M Decker, J. Use of dopamine in acute renal faiulre: a meta analysis. Crit.Care Med., 2001, 29(8), 1526-31.
85. Kellum, J.A. Systematic review: The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit. Care, 1997, 1(2), 53-59.
86. Bellomo, R.; Chapman, M.; Hickling, K.; Myburgh, J. Low-dose dopamine in patients with early renal dysfunction: a placebocontrolled randomised trial. The Lancet, 2000, 356(9248), 2139-2143.
87. Lauschke, A.; Teichgraber, U.K.M.; Frei, U.; Eckardt, K.U. Lowdose dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int., 2006, 69(9), 1669-1674.
88. Tumlin, J.A.; Finkel, K.W.; Murray, P.T.; Samuels, J.; Cotsonis, G.; Shaw, A.D. Fenoldopam Mesylate in Early Acute Tubular Necrosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Am. J. Kidney Dis., 2005, 46(1), 26-34.
89. Furuichi, K.; Wada, T.; Iwata, Y.; Sakai, N.; Yoshimoto, K.; Kobayashi, K.; Mukaida, N.; Matsushima, K.; Yokoyama, H. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrol. Dial. Transplant., 2002, 17(3), 399-407.
90. Miyazawa, S.; Watanabe, H.; Miyaji, C.; Hotta, O.; Abo, T. Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice. J. Lab. Clin. Med., 2002, 139(5), 269-278.
91. Ysebaert, D.K.; De Greef, K.E.; Vercauteren, S.R.; Ghielli, M.; Verpooten, G.A.; Eyskens, E.J.; De Broe, M.E. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol. Dial. Transplant., 2000, 15(10), 1562-1574.
92. Kinsey, G.R.; Li, L.; Okusa, M.D. Inflammation in Acute Kidney Injury. Nephron. Exp. Nephrol., 2008, 109(4), e102-e107.
93. Friedewald, J.J.; Rabb, H. Inflammatory cells in ischemic acute renal failure. Kidney Int., 2004, 66 (2), 486-491.
94. Molitoris, B.A.; Sandoval, R.; Sutton, T.A. Endothelial injury and dysfunction in ischemic acute renal failure. Crit. Care Med., 2002, 30(5), S235-40.
95. Kelly, K.J.; Williams, W.W., Jr.; Colvin, R.B.; Bonventre, J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA., 1994, 91(2), 812-6.
96. Fuller, T.F.; Sattler, B.; Binder, L.; Vetterlein, F.; Ringe, B.; Lorf, T. Reduction of severe ischemia/reperfusion injury in rat idney grafts by a soluble P-Selectin glycprotein ligand. Tranplantation, 2001, 72, 216-222.
97. Kelly, K.J.; Sutton, T.A.; Weathered, N.; Ray, N.; Caldwell, E. J.; Plotkin, Z.; Dagher, P.C. Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury. Am J. Physiol., 2004, 287, F760-F766.
98. Sharfuddin, A.A.; Sandoval, R.M.; Berg, D.T.; McDougal, G.E.; Campos, S.B.; Phillips, C.L.; Jones, B.E.; Gupta, A.; Grinnell, B.W.; Molitoris, B.A. Soluble Thrombomodulin Protects Ischemic Kidneys. J. Am. Soc. Nephrol., 2009, 20(3), 524-534.
99. Kelly, K.J.; Williams, W.W., Jr.; Colvin, R.B.; Meehan, S.M.; Springer, T.A.; Gutierrez-Ramos, J.C.; Bonventre, J.V. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Investig., 1996, 97(4), 1056-63.
100. Friedewald, J.J.; Rabb, H. Inflammatory cells in ischemic acute renal failure. Kidney Internat., 2004, 66(2), 486-91.
101. Haug, C.E.; Colvin, R.B.; Delmonico, F.L.; Auchincloss, H.J.; Tolkoffrubin, N.; Preffer, F.I.; Rothlein, R.; Norris, S.; Scharschmidt, L.; Cosimi, A.B. A Phase I Trial of Immunosuppression with Antiic AM-1 (CD54) mAb in Renal Allograft Recipients. Transplantation, 1993, 55(4), 766-772.
102. Salmela, K.; Wramner, L.; Ekberg, H.; Hauser, I.; Bentdal, A. Y.; Lins, L.-E.; Isoniemi, H.; Backman, L.; Persson, N.; Neumayer, H.-H.; Jargensen, P.L.F.; Spieker, C.; Hendry, B.; Nicholls, A.; Kirste, G.N.; Hasche, G. A randomized multicenter trial of the anti- ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation, 1999, 67(5), 729-736.
103. Enestrom, S.; Druid, H.; Rammer, L. Fibrin deposition in the kidney in post-ischaemic renal damage. Br. J. Exp. Pathol., 1988, 69, 387-394.
104. Matsuyama, M.; Yoshimura, R.; Akioka, K.; Okamoto, M.; Ushigome, H.; Kadotani, Y.; Nakatani, T.; Yoshimura, M. Tissue factor antisense oligonucleotides prevent renal ischema reperfusion injury. Tranplantation, 2003, 76, 786-791.
105. Gupta, A.; Williams, M.D.; Macias, W.L.; Molitoris, B.; Grinnell, B. Activated protein C and acute kidney injury: Selective Targeting of PAR-1. Curr. Drug Targets., 2009, 10, 1212-26.
106. Bernard, G.R.; Vincent, J.-L.; Laterre, P.-F.; LaRosa, S.P.; Dhainaut, J.-F.; Lopez-Rodriguez, A.; Steingrub, J.S.; Garber, G.E.; Helterbrand, J.D.; Ely, E.W.; Fisher, C.J. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis. N. Engl. J. Med., 2001, 344(10), 699-709.
107. Ranieri, V.M.; Thompson, B.T.; Barie, P.S.; Dhainaut, J.-F.; Douglas, I.S.; Finfer, S.; Gardlund, B.; Marshall, J.C.; Rhodes, A.; Artigas, A.; Payen, D.; Tenhunen, J.; Al-Khalidi, H.R.; Thompson, V.; Janes, J.; Macias, W.L.; Vangerow, B.; Williams, M.D. Drotrecogin Alfa (Activated) in Adults with Septic Shock. N. Engl. J. Med., 2012, 366 (22), 2055-2064.
108. Yang, L.; Besschetnova, T.Y.; Brooks, C.R.; Shah, J.V.; Bonventre, J.V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med., 2010, 16(5), 535-543.
109. Venkatachalam, M.A.; Griffin, K.A.; Lan, R.; Geng, H.; Saikumar, P.; Bidani, A.K. Acute kidney injury: a springboard for progression in chronic kidney disease. Am. J. Physiol. Renal Physiol., 2010, 298 (5), F1078-F1094.
110. Zager, R.A.; Johnson, A.C.M. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am. J. Physiol. Renal Physiol., 2009, 296(5), F1032-F1041.
111. Kim, J.; Seok, Y.M.; Jung, K.-J.; Park, K.M. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am. J. Physiol. Renal Physiol., 2009, 297(2), F461-F470.
112. Basile, D.P.; Donohoe, D.L.; Roethe, K.; Osborn, J.L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol., 2001, 281(10), F887-F899.
113. Basile, D.P.; Donohoe, D.L.; Roethe, K.; Mattson, D.L. Chronic renal hypoxia following ischemia/reperfusion injury: Effects of LArginine on hypoxia and secondary damage. Am. J. Physiol. Renal Physiol., 2003, 284, F338-348.
114. Horbelt, M.; Lee, S.-Y.; Mang, H.E.; Knipe, N.L.; Sado, Y.; Kribben, A.; Sutton, T.A. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol., 2007, 293(3), F688-695.
115. Kwon, O.; Hong, S.-M.; Sutton, T.A.; Temm, C.J. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am. J. Physiol. Renal Physiol., 2008, 295(2), F351-359.
116. Steegh, F.M.E.G.; Gelens, M.A.C.J.; Nieman, F.H.M.; van Hooff, J.P.; Cleutjens, J.P.M.; van Suylen, R.J.; Daemen, M.J. A.P.; van Heurn, E.L.W.; Christiaans, M.H.L.; Peutz-Kootstra, C.J. Early Loss of Peritubular Capillaries after Kidney Transplantation. J. Am. Soc. Nephrol., 2011, 22(6), 1024-1029.
117. Basile, D.P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int., 2007, 72, 151-156.
118. Basile, D.P. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing progressive nephropathy. Curr. Opin. Nephrol. Hyperten., 2004, 13, 1-13.
119. Norman, J.; Fine, L.G. Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol., 2006, 33, 989-996.
120. Pechman, K.R.; De Miguel, C.; Lund, H.; Leonard, E.C.; Basile, D. P.; Mattson, D.L. Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2009, 297 (5), R1358-1363.
121. Spurgeon-Pechman, K.R.; Donohoe, D.L.; Mattson, D.L.; Lund, H.; James, L.; Basile, D.P. Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am. J. Physiol. Renal Physiol., 2007, 293, F269-278.
122. Basile, D.P.; Friedrich, J.L.; Spahic, J.; Knipe, N.L.; Mang, H.E.; Leonard, E.C.; Ashtiyani, S.C.; Bacallao, R.L.; Molitoris, B.A.; Sutton, T.A. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Renal. Physiol., 2011, 300, F721-33.
123. Leonard, E.C.; Friderich, J.; Basile, D.P. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am. J. Physiol. Renal. Physiol., 2008, 295, F1648-57.
124. Lee, H.T.; Park, S.W.; Kim, M.; D'Agati, V.D. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab. Invest., 2008, 89(2), 196-208.
125. Kida, Y.; Ieronimakis, N.; Schrimpf, C.; Reyes, M.; Duffield, J.S. EphrinB2 Reverse Signaling Protects against Capillary Rarefaction and Fibrosis after Kidney Injury. J. Am. Soc. Nephrol., 2013, 24(4), 559-572.
126. Basile, D.P.; Rovak, J.M.; Martin, D.R.; Hammerman, M.R. Increased transforming growth factor-ß expression in regenerating rat renal tubules following ischemic injury. Am. J. Physiol., 1996, 270(39), F500-F509.
127. Spurgeon, K.S.; Donohoe, D.L.; Basile, D.P. Transforming growth factor-ß in acute renal failure: receptor expression, influence in cell proliferation, cellularity and vascularization after recovery from injury. Am J. Physiol. Renal. Physiol., 2005, 288, F568-F577.
128. Basile, D.P.; Fredrich, K.; Weihrauch, D.W.; Hattan, N.; Chilian, W.M. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J. Physiol. Renal. Physiol., 2004, 286, F893-F902.
129. Basile, DP.; Fredrich, K.; Chelladurai, B.; Leonard, E.C.; Parrish, A.R. Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor. Am J. Physiol. Renal. Physiol., 2008, 294.
130. Kanellis, J.; Paizis, K.; Cox, A.J.; Stacker, S.A.; Gilbert, R.E.; Cooper, M.E.; Power, D.A. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kidney Int., 2002, 61(5), 1696-706.
131. Johnson, R.J.; Schreiner, G.F. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int., 1997, 52(5), 1169-79.
132. Suga, S.; Kim, Y.G.; Joly, A.; Puchacz, E.; Kang, D.H.; Jefferson, J.A.; Abraham, J.A.; Hughes, J.; Johnson, R. J.; Schreiner, G.F. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int., 2001, 60(4), 1297-308.
133. Kang, D.H.; Hughes, J.; Mazzali, M.; Schreiner, G.F.; Johnson, R.J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol., 2001, 12(7), 1448-57.
134. Jung, Y.J.; Kim, D.H.; Lee, A.S.; Lee, S.; Kang, K.P.; Lee, S.Y.; Jang, K.Y.; Sung, M.J.; Park, S.K.; Kim, W. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemiareperfusion- induced acute kidney injury. Am. J. Physiol Renal Physiol., 2009, 297(4), F952-F960.
135. Zhang, B.; Chen, N.; Shi, W.; Wang, W.; Shi, H.; Yu, H. Peritubular Capillary Loss Is Ameliorated by Ramipril or Valsartan Treatment. Microcirculation, 2008, 15 (4), 337-348.
136. Long, D.; Mu, W.; Price, K.; Roncal, C.; Schreiner, G.F.; Woolf, A.S.; Johnson, R. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post angiotensin II hypertension. Am J. Physiol., 2006, 291, F1248-54.
137. Chade, A.R.; Kelsen, S. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Am J. Physiol.- Renal Physiol., 2012, 302(10), F1342-F1350.
138. Freeburg, P.B.; Abrahamson, D.R. Hypoxia-Inducible Factors and Kidney Vascular Development. J. Am. Soc. Nephrol., 2003, 14(11), 2723-2730.
139. Nyengaard, J.; Rasch, R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia, 1993, 36(3), 189-194.
140. Ostendorf, T.; Kunter, U.; Eitner, F.; Loos, A.; Regele, H.; Kerjaschki, D.; Henninger, D.D.; Janjic, N.; Floege, J.R. VEGF165 mediates glomerular endothelial repair. J.Clin. Investig., 1999, 104(7), 913-923.
141. Nangaku, M.; Alpers, C.E.; Pippin, J.; Shankland, S.J.; Adler, S.; Kurokawa, K.; Couser, W.G.; Johnson, R. J. A new model of renal microvascular endothelial injury. Kidney Internat., 1997, 52(1), 182-94.
142. Iruela-Arispe, L.; Gordon, K.; Hugo, C.; Duijvestijn, A.; Claffey, K.; Reilly, M.; Couser, W.; Alpers, C.; Johnson, R. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am. J. Pathol., 1995, 147(6), 1715-1727.
143. Floege, J.; Burns, M.W.; Alpers, C.E.; Yoshimura, A.; Pritzl, P.; Gordon, K.; Seifert, R.A.; Bowen-Pope, D.F.; Couser, W.G.; Johnson, R.J. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int., 1992, 41(2), 297-309.
144. Hohenstein, B.; Kuo, M.-C.; Addabbo, F.; Yasuda, K.; Ratliff, B.; Schwarzenberger, C.; Eckardt, K.-U.; Hugo, C.P.M.; Goligorsky, M.S. Enhanced progenitor cell recruitment and endothelial repair after selective endothelial injury of the mouse kidney. Am. J. Physiol. Renal Physiol., 2010, 298(6), F1504-F1514.
145. Basile, D.P.; Friedrich, J.L.; Spahic, J.; Knipe, N.L.; Mang, H.E.; Leonard, E.C.; Ashtiyani, S.C.; Bacallao, R.L.; Molitoris, B.A.; Sutton, T.A. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Renal Physiol., 2011, 300(3), F721-33.
146. Lin, S.; Chang, F.; Schrimpf, C.; Chen, Y.; Wu, C.; Wu, V.; Chiang, W.; Kuhnert, F.; Kuo, C.; Chen, Y.; Wu, K.; Tsai, T.; Duffield, J. Targetting endothelium pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am. J. Pathol., 2011, 178, 911-23.
147. Schrimpf, C.; Xin, C.; Campanholle, G.; Gill, S.; Stallcup, W.; Lin, S.; David, G.; Gharib, S.; Humphreys, B.D.; Duffield, J.S. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J. Am. Soc. Nephrol., 2012, 23(5), 868-83
148. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J.M. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science, 1997, 275 (5302), 964-966.
149. Kogler, G.; Critser, P.; Trapp, T.; Yoder, M. Future of cord blood for non-oncology uses. Bone Marrow Transplant, 2009, 44(10), 683-697.
150. Patschan, D.; Patschan, S.; Muller, G.A. Endothelial Progenitor Cells in Acute Ischemic Kidney Injury: Strategies for Increasing the Cells' Renoprotective Competence. Intern. J. Nephrol., 2011, 2011, 828369.
151. Yoder, M.C.; Mead, L.E.; Prater, D.; Krier, T.R.; Mroueh, K.N.; Li, F.; Krasich, R.; Temm, C.J.; Prchal, J.T.; Ingram, D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 2007, 109(5), 1801-1809.
152. Asahara, T.; Kawamoto, A.; Masuda, H., Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine. Stem Cells, 2011, 29 (11), 1650-1655.
153. Rookmaaker, M.B.; Verhaar, M.C.; van Zonneveld, A. J.; Rabelink, T.J. Progenitor cells in the kidney: biology and therapeutic perspectives. Kidney Intern., 2004, 66(2), 518-22.
154. Li, J.; Deane, J.A.; Campanale, N.V.; Bertram, J.F.; Ricardo, S.D. Blockade of p38 Mitogen-Activated Protein Kinase and TGFbeta/ Smad Signaling Pathways Rescues Bone Marrow-Derived Peritubular Capillary Endothelial Cells in Adriamycin-Induced Nephrosis. J. Am. Soc. Nephrol., 2006, 17(10), 2799-2811.
155. Duffield, J.S.; Park, K.M.; Hsiao, L.-L.; Kelley, V.R.; Scadden, D.T.; Ichimura, T.; Bonventre, J.V. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. [see comment]. J. Clin. Investig., 2005, 115 (7), 1743-55.
156. Yoder, M.C. Defining human endothelial progenitor cells. J. Thromb. Haemost., 2009, 7(s1), 49-52.
157. Assmus, B.; Honold, J.r.; Schachinger, V.; Britten, M.B.; Fischer-Rasokat, U.; Lehmann, R.; Teupe, C.; Pistorius, K.; Martin, H.; Abolmaali, N.D.; Tonn, T.; Dimmeler, S.; Zeiher, A.M. Transcoronary Transplantation of Progenitor Cells after Myocardial Infarction. New Engl. J. Med., 2006, 355(12), 1222-1232.
158. Napoli, C.; Hayashi, T.; Cacciatore, F.; Casamassimi, A.; Casini, C.; Al-Omran, M.; Ignarro, L.J. Endothelial progenitor cells as therapeutic agents in the microcirculation: An update. Atherosclerosis, 2010, 215(1), 9-22.
159. Rehman, J.; Li, J.; Orschell, C.M.; March, K.L. Peripheral Blood Endothelial Progenitor Cells Are Derived From Monocyte/ Macrophages and Secrete Angiogenic Growth Factors. Circulation, 2003, 107 (8), 1164-1169.
160. Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J.M. Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization. Circ. Res., 1999, 85(3), 221-228.
161. Yasuda, K.; Park, H.-C.; Ratliff, B.; Addabbo, F.; Hatzopoulos, A.K.; Chander, P.; Goligorsky, M.S. Adriamycin Nephropathy: A Failure of Endothelial Progenitor Cell-Induced Repair. Am. J. Pathol., 2010 176(4), 1685-1695.
162. Patschan, D.; Krupincza, K.; Patschan, S.; Zhang, Z.; Hamby, C.; Goligorsky, M.S. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am. J. Physiol. Renal Physiol., 2006, 291(1), F176-F185.
163. Schwarz, T.M.; Leicht, S. F.; Radic, T.; Rodriguez-Araboalaza, I.; Hermann, P.C.; Berger, F.; Saif, J.; Becker, W.; Ellwart, J. W.; Aicher, A.; Heeschen, C. Vascular Incorporation of Endothelial Colony-Forming Cells Is Essential for Functional Recovery of Murine Ischemic Tissue Following Cell Therapy. Arterioscler. Thromb. Vasc. Biol., 2011, 32(2), e13-e21.
164. Ingram, D.A.; Caplice, N.M.; Yoder, M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood, 2005, 106(5), 1525-31.
165. Yoon, C.-H.; Hur, J.; Park, K.-W.; Kim, J.-H.; Lee, C.-S.; Oh, I.- Y.; Kim, T.-Y.; Cho, H.-J.; Kang, H.-J.; Chae, I.-H.; Yang, H.-K.; Oh, B.-H.; Park, Y.-B.; Kim, H.-S., Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells. Circulation 2005, 112 (11), 1618-1627.
166. Yoder, M. C., Is Endothelium the Origin of Endothelial Progenitor Cells? Arterioscler. Thromb. Vasc. Biol., 2010, 30(6), 1094-1103.
167. Basile, D. P.; Zeng, P.; Friedrich, J. L.; Leonard, E.; Yoder, M. C., Low proliferative potential and impaired angiogenesis of cultured rat kidney endothelial cells. Microcirculation, 2012, 19, 598-609.